← Back to headlines
Guggenheim Trims Amgen Price Target to $340
Guggenheim has adjusted its price target for biotech giant Amgen, lowering it to $340. The move prompts questions about Amgen's competitive position and future growth prospects in the market.
4 May, 14:50 — 4 May, 14:50
Sources
Showing 1 of 1 sources